Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Expression patterns of the immunosuppressive proteins PD-1/CD279 and PD-L1/CD274 at different stages of cutaneous T-cell lymphoma/mycosis fungoides.

Kantekure K, Yang Y, Raghunath P, Schaffer A, Woetmann A, Zhang Q, Odum N, Wasik M.

Am J Dermatopathol. 2012 Feb;34(1):126-8. doi: 10.1097/DAD.0b013e31821c35cb. No abstract available.

2.

PD1 (CD279) and PD-L1 (CD274, B7H1) expression in primary central nervous system lymphomas (PCNSL).

Berghoff AS, Ricken G, Widhalm G, Rajky O, Hainfellner JA, Birner P, Raderer M, Preusser M.

Clin Neuropathol. 2014 Jan-Feb;33(1):42-9.

PMID:
24359606
3.

Clusterin expression correlates with stage and presence of large cells in mycosis fungoides.

Chandra P, Plaza JA, Zuo Z, Diwan AH, Koeppen H, Duvic M, Medeiros LJ, Prieto VG.

Am J Clin Pathol. 2009 Apr;131(4):511-5. doi: 10.1309/AJCPH43ZDVLSOSNB.

4.

Differential expression of Fas in tumour-stage mycosis fungoides (MF) and MF-like cutaneous T-cell pseudolymphoma.

Debusscher C, Simonart T.

Br J Dermatol. 2001 Apr;144(4):903. No abstract available.

PMID:
11298560
5.

Mycosis fungoides: classic disease and variant presentations.

Howard MS, Smoller BR.

Semin Cutan Med Surg. 2000 Jun;19(2):91-9. Review.

PMID:
10892710
6.

FOXP3 in sequential biopsies of progressive mycosis fungoides.

Fried I, Cerroni L.

Am J Dermatopathol. 2012 May;34(3):263-5. doi: 10.1097/DAD.0b013e31823062db.

PMID:
22157245
7.

[Research update on PD-1/PD-L1 pathway in hematological diseases].

Li Y, Wang J, Ke XY.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Dec;19(6):1523-7. Review. Chinese.

PMID:
22169317
8.

CD20 antigen may be expressed by reactive or lymphomatous cells of transformed mycosis fungoides: diagnostic and prognostic impact.

Jullié ML, Carlotti M, Vivot A Jr, Beylot-Barry M, Ortonne N, Frouin E, Carlotti A, de Muret A, Balme B, Franck F, Merlio JP, Vergier B.

Am J Surg Pathol. 2013 Dec;37(12):1845-54. doi: 10.1097/PAS.0000000000000091.

PMID:
24145652
9.

Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer.

Maine CJ, Aziz NH, Chatterjee J, Hayford C, Brewig N, Whilding L, George AJ, Ghaem-Maghami S.

Cancer Immunol Immunother. 2014 Mar;63(3):215-24. doi: 10.1007/s00262-013-1503-x. Epub 2013 Dec 3.

PMID:
24297569
10.

Decreased CD117 expression in hypopigmented mycosis fungoides correlates with hypomelanosis: lessons learned from vitiligo.

Singh ZN, Tretiakova MS, Shea CR, Petronic-Rosic VM.

Mod Pathol. 2006 Sep;19(9):1255-60. Epub 2006 Jun 16.

11.

Epidermotropic secondary cutaneous involvement by relapsed angioimmunoblastic T-cell lymphoma mimicking mycosis fungoides: a case report.

Ponciano A, de Muret A, Machet L, Gyan E, Monegier du Sorbier C, Molinier-Frenkel V, Gaulard P, Ortonne N.

J Cutan Pathol. 2012 Dec;39(12):1119-24. doi: 10.1111/cup.12022. Epub 2012 Oct 10.

PMID:
23046157
12.

Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.

Fraser-Andrews EA, Mitchell T, Ferreira S, Seed PT, Russell-Jones R, Calonje E, Whittaker SJ.

Br J Dermatol. 2006 Oct;155(4):756-62.

PMID:
16965425
13.

Pathogenesis of Mycosis fungoides.

Beyer M, Möbs M, Humme D, Sterry W.

J Dtsch Dermatol Ges. 2011 Aug;9(8):594-8. doi: 10.1111/j.1610-0387.2011.07635.x. Epub 2011 Mar 3. Review. English, German.

PMID:
21371258
14.

T-cell receptor-gamma gene analysis in evolving to advancing cutaneous T-cell lymphoma.

Foo CC, Tang MB, Chong TK, Sun YJ, Tan SH.

Australas J Dermatol. 2007 Aug;48(3):156-60.

PMID:
17680965
15.

Molecular pathways: next-generation immunotherapy--inhibiting programmed death-ligand 1 and programmed death-1.

Chen DS, Irving BA, Hodi FS.

Clin Cancer Res. 2012 Dec 15;18(24):6580-7. doi: 10.1158/1078-0432.CCR-12-1362. Epub 2012 Oct 19.

16.

Tumor PD-L1 co-stimulates primary human CD8(+) cytotoxic T cells modified to express a PD1:CD28 chimeric receptor.

Prosser ME, Brown CE, Shami AF, Forman SJ, Jensen MC.

Mol Immunol. 2012 Jul;51(3-4):263-72. doi: 10.1016/j.molimm.2012.03.023. Epub 2012 Apr 11.

PMID:
22503210
17.

The comparison of expression of cutaneous lymphocyte-associated antigen (CLA), and Th1- and Th2-associated antigens in mycosis fungoides and cutaneous lesions of adult T-cell leukemia/lymphoma.

Yamaguchi T, Ohshima K, Tsuchiya T, Suehuji H, Karube K, Nakayama J, Suzumiya J, Yoshino T, Kikuchi M.

Eur J Dermatol. 2003 Nov-Dec;13(6):553-9.

PMID:
14721775
18.
19.

Invisible mycosis fungoides: a diagnostic challenge.

Pujol RM, Gallardo F, Llistosella E, Blanco A, Bernadó L, Bordes R, Nomdedeu JF, Servitje O.

J Am Acad Dermatol. 2002 Aug;47(2 Suppl):S168-71.

PMID:
12140452
20.

Invisible mycosis fungoides: A diagnostic challenge.

Pujol RM, Gallardo F, Llistosella E, Blanco A, Bernadó L, Bordes R, Nomdedeu JF, Servitje O.

J Am Acad Dermatol. 2000 Feb;42(2 Pt 2):324-8.

PMID:
10640924
Items per page

Supplemental Content

Write to the Help Desk